You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Thiazolidinediones and Congestive Heart Failure: A Judicious Balance of Risks and Benefits

Patel, Rujul R. DO

Cardiology in Review:
doi: 10.1097/CRD.0b013e31819faab2
Review Article
Abstract

Thiazolidinediones are oral antihyperglycemic drugs that have gained significant popularity for use in the treatment of type 2 diabetes mellitus. Their insulin sensitizing effects lead to better glycemic control, in addition to improvements in several cardiovascular parameters independent of blood glucose levels. The pleiotropic effects of thiazolidinediones have led to several cardiovascular outcome studies, many of which have shown promising data, but some of which bring about significant concern. Additionally, the propensity to cause weight gain, fluid retention, peripheral edema, and increased risk of heart failure hospitalizations continue to pose significant challenges for clinicians using these agents in patients with congestive heart failure.

Author Information

From the Department of Internal Medicine, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania.

Correspondence: Rujul R. Patel, DO, 202 Dresher Woods Drive, Dresher, PA 19025. E-mail: rujulrp@gmail.com.

© 2009 Lippincott Williams & Wilkins, Inc.